Diltiazem-associated Photodistributed Hyperpigmentation.

Jacob D Siegel, Christine J Ko

The Yale journal of biology and medicine 2020 Mar

filter terms:

Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmentation 6 months after initiating treatment with diltiazem. Copyright ©2020, Yale Journal of Biology and Medicine.

Citation

Jacob D Siegel, Christine J Ko. Diltiazem-associated Photodistributed Hyperpigmentation. The Yale journal of biology and medicine. 2020 Mar;93(1):45-47